TANG CAPITAL MANAGEMENT LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$502.4B
Holdings
16
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRTXHERON THERAPEUTICS INC | 7,907,087 | $122.7B | 24.43% | |
| 2 | RCKTROCKET PHARMACEUTICALS INC | 2,531,800 | $112.1B | 22.32% | |
| 3 | ANABANAPTYSBIO INC | 2,628,678 | $68.2B | 13.57% | |
| 4 | —ODONATE THERAPEUTICS INC | 15,514,566 | $54.1B | 10.78% | |
| 5 | —LA JOLLA PHARMACEUTICAL CO | 10,049,224 | $43.0B | 8.56% | |
| 6 | APVOAPTEVO THERAPEUTICS INC | 1,760,000 | $39.5B | 7.86% | |
| 7 | —VINCERX PHARMA INC | 1,030,634 | $13.4B | 2.66% | |
| 8 | CHRSCOHERUS BIOSCIENCES INC | 650,000 | $9.0B | 1.79% | |
| 9 | ALTALTIMMUNE INC | 783,407 | $7.7B | 1.54% | |
| 10 | CCXIEURCHEMOCENTRYX INC | 500,000 | $6.7B | 1.33% | |
| 11 | —REVIVA PHARMACEUTCLS HLDGS I | 1,200,000 | $5.8B | 1.16% | |
| 12 | 5E7ITEOS THERAPEUTICS INC | 219,396 | $5.6B | 1.12% | |
| 13 | —BCTG ACQUISITION CORP | 468,750 | $5.3B | 1.06% | |
| 14 | EQEQUILLIUM INC | 600,000 | $3.5B | 0.70% | |
| 15 | RLMDRELMADA THERAPEUTICS INC | 100,000 | $3.2B | 0.64% | |
| 16 | NXTCNEXTCURE INC | 300,000 | $2.4B | 0.48% |